Michael S. Weiss, Chairman and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 18,500 shares at $14.41 ($268K) on 2006-12-11, disclosed to the SEC on 2006-12-11.
Scheduled sale ($268k) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.40 | 1,500 | $22K | 8.1% |
| 2 | $14.41 | 2,000 | $29K | 10.8% |
| 3 | $14.43 | 1,000 | $14K | 5.4% |
| 4 | $14.45 | 3,000 | $43K | 16.2% |
| 5 | $14.46 | 1,000 | $14K | 5.4% |
| 6 | $14.47 | 1,000 |
| $14K |
| 5.4% |
| 7 | $14.50 | 8,000 | $116K | 43.3% |
| 8 | $14.51 | 1,000 | $15K | 5.4% |
| Total | $14.47 avg | 18,500 | $268K | 100% |
| Filing → |
| FBIO | BUY | 2023-02-14 | $2.0M | — | Filing → |
| TGTX | SELL | 2022-01-07 | $2.6M | — | Filing → |
| TGTX | BUY | 2019-06-27 | $352K | — | Filing → |